ROLE OF PHOSPHORYLATION OF CTNL IN THE REGULATION OF MYOCARDIUM
ROLE OF PHOSPHORYLATION OF CTNL IN THE REGULATION OF MYOCARDIUM
批准号:
8361296
负责人:
MICHAEL REGNIER
金额:
$1.97万
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-01-01 至 2011-12-31
关键词:
Adrenergic AgentsBiophysicsCardiacCardiac MyosinsCyclic AMP-Dependent Protein KinasesDependenceFundingGrantLeftLengthMeasuresMicrofilamentsMyocardiumNational Center for Research ResourcesPhosphorylationPreparationPrincipal InvestigatorRattusRegulationResearchResearch InfrastructureResourcesRoleSkinSourceTroponinTroponin IUnited States National Institutes of Healthadrenergiccitrate carrierconnectincostinsightmutantmyosin-binding protein C
中文摘要
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the resources
provided by a Center grant funded by NIH/NCRR. Primary support for the subproject
and the subproject's principal investigator may have been provided by other sources,
including other NIH sources. The Total Cost listed for the subproject likely
represents the estimated amount of Center infrastructure utilized by the subproject,
not direct funding provided by the NCRR grant to the subproject or subproject staff.
¿-adrenergic modulation of cardiac contractility occurs, in part, through protein kinase A (PKA) myofibrillar protein phosphorylation. PKA targets the N-terminus of cardiac troponin I (cTnI), cardiac myosin-binding protein C (cMyBP-C) and titin. To isolate the effects of cTnI phosphorylation from cMyBP-C/titin phosphorylation on force-[Ca2+] relations, endogenous cardiac troponin (cTn) in rat skinned trabeculae was passively exchanged with either WT cTn, cTn containing a non-phosphorylatable cTnI(S23/24A) mutant, or a phosphomimetic cTnI(S23/24D) mutant. PKA cannot phosphorylate either cTnI mutant, thus leaving MyBP-C and titin as the sole PKA targets in those preparations. Force-[Ca2+] relationships and Ca2+-sensitivity (pCa50) were measured at 2.3 and 2.0 ¿m SL. pCa50 was similar between WT Tn and Tn containing cTnI(S23/24A) trabeculae at both long and short SL, with decreased pCa50 at short SL. PKA treatment of WT and cTnI(S23,24A) exchanged trabeculae reduced pCa50 at both SL, but to a greater extent 2.3 um SL, eliminating the SL-dependence of pCa50 for both conditions. Exchange with cTn containing cTnI(S23/24D) reduced pCa50 at both SL (compared to WT and cTnI(S23,24A)) and also eliminated the influence of SL on pCa50. In summary, phosphorylation of cTnI and cardiac C-protein/titin both independently reduced pCa50, but to greater extents at longer SLs, thus reducing length dependence of Ca2+ sensitivity of force. In order to get insight into why this is so, small-angle x-ray diffraction was performed to determine whether these shifts in pCa50 were associated with changes in myofilament spacing or interaction.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Bioengineering Cardiovascular Training Grant (BCTG)
-
批准号:10418471
-
项目类别:
-
资助金额:$19.98万
-
财政年份:2022
-
负责人:MICHAEL REGNIER
-
依托单位:
Bioengineering Cardiovascular Training Grant (BCTG)
-
批准号:10650834
-
项目类别:
-
资助金额:$20.22万
-
财政年份:2022
-
负责人:MICHAEL REGNIER
-
依托单位:
Mechanics and Devices
-
批准号:10612116
-
项目类别:
-
资助金额:$25.32万
-
财政年份:2019
-
负责人:MICHAEL REGNIER
-
依托单位:
Administration and Enrichment
-
批准号:10612115
-
项目类别:
-
资助金额:$36.14万
-
财政年份:2019
-
负责人:MICHAEL REGNIER
-
依托单位:
Engineered Stem Cells for Cardiac Repair
-
批准号:10442970
-
项目类别:
-
资助金额:$80.98万
-
财政年份:2018
-
负责人:MICHAEL REGNIER
-
依托单位:
Engineered Stem Cells for Cardiac Repair
-
批准号:10588153
-
项目类别:
-
资助金额:$78.83万
-
财政年份:2018
-
负责人:MICHAEL REGNIER
-
依托单位:
Myocardial Infarct in Aging Animals and dATP Therapy
-
批准号:9565690
-
项目类别:
-
资助金额:$68.26万
-
财政年份:2017
-
负责人:MICHAEL REGNIER
-
依托单位:
Training Core
-
批准号:10712150
-
项目类别:
-
资助金额:$10.59万
-
财政年份:2014
-
负责人:MICHAEL REGNIER
-
依托单位:
EFFECT OF R1R2 OVER-EXPRESSION ON CARDIAC FUNCTION
-
批准号:8891479
-
项目类别:
-
资助金额:$57.55万
-
财政年份:2012
-
负责人:MICHAEL REGNIER
-
依托单位:
EFFECT OF R1R2 OVER-EXPRESSION ON CARDIAC FUNCTION
-
批准号:8529267
-
项目类别:
-
资助金额:$55.62万
-
财政年份:2012
-
负责人:MICHAEL REGNIER
-
依托单位:
EFFECT OF R1R2 OVER-EXPRESSION ON CARDIAC FUNCTION
-
批准号:8708949
-
项目类别:
-
资助金额:$57.26万
-
财政年份:2012
-
负责人:MICHAEL REGNIER
-
依托单位:
EFFECT OF R1R2 OVER-EXPRESSION ON CARDIAC FUNCTION
-
批准号:8386360
-
项目类别:
-
资助金额:$58.12万
-
财政年份:2012
-
负责人:MICHAEL REGNIER
-
依托单位:
Building Bridges to Bioengineering
-
批准号:8220758
-
项目类别:
-
资助金额:$15.58万
-
财政年份:2010
-
负责人:MICHAEL REGNIER
-
依托单位:
Building Bridges to Bioengineering
-
批准号:8451404
-
项目类别:
-
资助金额:$15.04万
-
财政年份:2010
-
负责人:MICHAEL REGNIER
-
依托单位:
Building Bridges to Bioengineering
-
批准号:8662276
-
项目类别:
-
资助金额:$15.59万
-
财政年份:2010
-
负责人:MICHAEL REGNIER
-
依托单位:
Bioengineering Cardiovascular Training Grant
-
批准号:7227727
-
项目类别:
-
资助金额:$28.65万
-
财政年份:2004
-
负责人:MICHAEL REGNIER
-
依托单位:
Bioengineering Cardiovascular Training Grant
-
批准号:8103881
-
项目类别:
-
资助金额:$22.27万
-
财政年份:2004
-
负责人:MICHAEL REGNIER
-
依托单位:
Bioengineering Cardiovascular Training Grant
-
批准号:9102097
-
项目类别:
-
资助金额:$24.34万
-
财政年份:2004
-
负责人:MICHAEL REGNIER
-
依托单位:
Bioengineering Cardiovascular Training Grant
-
批准号:7942517
-
项目类别:
-
资助金额:$21.84万
-
财政年份:2004
-
负责人:MICHAEL REGNIER
-
依托单位:
Bioengineering Cardiovascular Training Grant
-
批准号:8507005
-
项目类别:
-
资助金额:$22.55万
-
财政年份:2004
-
负责人:MICHAEL REGNIER
-
依托单位:
海外基金